Creative Planning’s aTyr Pharma ATYR Stock Holding History

Creative Planning’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.8K	Buy	41,593 +31,085	+296%	+$20.3K	﹤0.01%	4179
2026 Q1	$8.2K	Buy	+10,508	New	+$8.87K	﹤0.01%	4078
2025 Q3	–	Sell	-14,509	Closed	-$73.6K	–	4037
2025 Q2	$73.6K	Buy	+14,509	New	+$57.1K	﹤0.01%	3472
2018 Q2	–	Sell	-1,214	Closed	-$45K	–	2186
2018 Q1	$45K	Hold	1,214	–	–	﹤0.01%	1826
2017 Q4	$60K	Hold	1,214	–	–	﹤0.01%	1788
2017 Q3	$86K	Hold	1,214	–	–	﹤0.01%	1733
2017 Q2	$58K	Sell	1,214 -86	-7%	-$4.03K	﹤0.01%	2407
2017 Q1	$64K	Buy	1,300 +371	+40%	+$17K	﹤0.01%	2294
2016 Q4	$28K	Buy	929 +358	+63%	+$14.7K	﹤0.01%	2847
2016 Q3	$25K	Hold	571	–	–	﹤0.01%	2908
2016 Q2	$22K	Buy	+571	New	+$26.5K	﹤0.01%	2736

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Creative Planning's ATYR Position: Q2 2026 in Review

Creative Planning increased its aTyr Pharma (ATYR) stake by 296% in Q2 2026, buying an estimated $20.3K and bringing the position to 41,593 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4179.

Creative Planning first reported a position in ATYR in Q2 2016 and has held it in 11 quarters since. The position peaked at $86K in Q3 2017. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

Creative Planning held 41,593 shares of aTyr Pharma worth $24.8K as of Q2 2026.
Creative Planning bought 31,085 aTyr Pharma shares in Q2 2026, an estimated $20.3K.
aTyr Pharma made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4179 holding.
Creative Planning first reported a position in aTyr Pharma in Q2 2016 and has held it in 11 quarters since.
Creative Planning's aTyr Pharma position peaked at $86K in Q3 2017.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.